You are not logged in
You need to be a member to print this page.
Sign up for free membership, or log in.
Find out more about our membership benefits
VIEW TAGS
Articles tagged ‘stent thrombosis’
October 2011
Br J Cardiol 2011;18:246-248
Recurrent stent thrombosis with dual antiplatelet resistance: the role of platelet function testing
Platelet activation is an important part of the pathophysiology of acute coronary syndromes. Inhibition of this by antiplatelet agents forms an important part of the...
September 2010
Br J Cardiol 2010;17:s3-s4
PCI in the UK – the continuing journey
A new and exciting ‘journey’ in interventional cardiology began more than 20 years ago with the introduction of intracoronary stenting....
September 2010
Br J Cardiol 2010;17:s5-s8
Intervention: who to treat and how?
Treatment options in ACS include optimised medical therapy, intervention and surgical revascularisation....
September 2010
Br J Cardiol 2010;17:s9-s14
Optimising medical treatment of ACS
The first widely used antiplatelet agent, aspirin, continues to be standard therapy in ACS patients. The meta-analysis of the Antithrombotic Trialists’ Collaboration showed a 40%...
November 2009
Br J Cardiol 2009;16:269-71
Clopidogrel needed for more than one year after drug-eluting stent placement?
Extending clopidogrel treatment from one to two years after drug-eluting stent placement is associated with a reduction in very late thromboses, new registry data suggest....
November 2008
Br J Cardiol 2008;15:326–8
The dark side of the drug-eluting stent: stent thrombosis with cessation of dual antiplatelet therapy
The use of drug-eluting stents (DES) has increased exponentially in recent years. There appears to be little difference in short- to medium-term safety compared with...
September 2007
Br J Cardiol 2007;14:234-6
Stent thrombosis and antiplatelet therapy: a review of 3,004 consecutive patients in a single centre
Stent thrombosis (ST) is an uncommon but serious complication of percutaneous coronary intervention (PCI), and is associated with the discontinuation of antiplatlet therapy. In a...
September 2006
Br J Cardiol 2006;13:313-16
Late clinical events after drug-eluting stents: is there a problem?
Recent presentations at the joint meeting of the European Society of Cardiology and World Congress of Cardiology in Barcelona, Spain, highlighted the potential problem of...